Agnès Jaulent studied for her PhD in chemistry at Imperial College London and then completed her post doctoral studies at the LMB (Laboratory for Molecular Biology) in Cambridge, UK. She then joined a biotech company that specialises in offering discovery services to the pharma industry in the fields of peptide, protein and antibody discovery. She is an expert in all fields pertaining to peptide chemistry and has experience working as a project manager.
At EspeRare, Agnes is, amongst other duties, responsible for the Cilengitide project.
Translational Project Leader
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.